- 16 January, 2025
Dogecoin gets back to pre-crash prices as $16M in DOGE shorts get liquidated
Dogecoin (DOGE) prices jumped by nearly 40% on a 24-hour adjusted timeframe on June 2, shaking out more than $16 million worth of bearish leverage
Nio stock price forecast as analysts remain bullish
The Nio (NYSE: NIO) stock price darted higher on Tuesday even after the company published weak May delivery numbers. The stock rose by more than
Regulators starting to take crypto seriously, CoinShares exec says
The $2.6 trillion market cap peak compelled regulators worldwide to take a serious look at cryptocurrencies, but they also don’t want to stifle a growing
Binance-backed Indonesian crypto exchange considers IPO
Jakarta-based crypto exchange Tokocrypto is considering a public market debut over the next two or three years, Nikkei reports Wednesday. “I’m saying two years because
Big rise in financial advisers adding crypto assets to client portfolios
According to a survey, financial advisers are recommending investments in Bitcoin and crypto assets to their clients more than ever before. A report by the
Here’s what Zoom’s Q1 earnings report tells us
Zoom Video Communications Inc. (NASDAQ: ZM) reported its financial results for the fiscal first quarter on Tuesday that beat Wall Street estimates. On the back
Polkadot ETP hits Swedish stock market
The mainstream financial world has taken notable strides to incorporate various crypto assets. A new exchange-traded product (ETP) for Polkadot (DOT) recently surfaced on a
Much hype: Memecoin DOGE set for listing on Coinbase Pro
Coinbase Pro, the professional trading arm of the Coinbase cryptocurrency exchange, has begun accepting inbound transfers for Dogecoin (DOGE), setting the stage for wider adoption
Even notable economist Mohamed El-Erian is weighing in on AMC stock
AMC Entertainment Holdings Inc (NYSE: AMC) jumped more than 20% in the stock market on Tuesday morning as Mudrick Capital Management (investment firm) bought over
Here’s why Abbott Laboratories lost 8% on Tuesday
Abbott Laboratories (NYSE: ABT) tanked 8% in the stock market on Tuesday morning as the health care company warned that its full-year profit was likely